Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2025 Oct 15:683:126012.
doi: 10.1016/j.ijpharm.2025.126012. Epub 2025 Jul 29.

Accelerated predictive stability (APS) strategies applied to screening pharmaceutical formulations: A comparison of spray dried and hot melt extruded nifedipine amorphous solid dispersions

Affiliations
Comparative Study

Accelerated predictive stability (APS) strategies applied to screening pharmaceutical formulations: A comparison of spray dried and hot melt extruded nifedipine amorphous solid dispersions

Peter O'Connell et al. Int J Pharm. .

Abstract

This study addresses the challenges in designing stable amorphous solid dispersions (ASDs) for pharmaceutical applications, focusing on nifedipine ASDs. The research involved manufacturing four different nifedipine ASDs using scalable pharmaceutical techniques-hot melt extrusion (HME) and spray drying (SD). Two pharmaceutical grade polymers, Soluplus® and poly-vinylpyrrolidone vinyl acetate (PVPVA, Kollidon® VA64), were used as carriers. The study employed an Accelerated Predictive Stability (APS) approach to assess the stability of these formulations. This included High-Performance Liquid Chromatography (HPLC) for quantifying nifedipine degradation, Powder X-Ray Diffraction (PXRD), and Differential Scanning Calorimetry (DSC) for measuring crystallisation kinetics. Additionally, Near-Infrared (NIR) spectroscopy was utilised to develop Partial Least Squares (PLS) regression models, providing a cost-effective and non-destructive method to quantify physicochemical changes. The results revealed that all four ASDs significantly improved the dissolution rate of nifedipine compared to its crystalline form. However, notable differences in stability among the formulations were observed through APS. The SD powders demonstrated greater physical stability, evidenced by a single glass transition temperature, in contrast to the extrudates, which showed dual glass transition temperatures indicating phase separation. Conversely, the HME formulations exhibited superior chemical stability compared to their SD counterparts, with the latter showing increased moisture sensitivity. Additionally, the degradation kinetics of the SD formulations were more complex than those of the extruded materials. Under less extreme conditions, SD systems followed Avrami-type kinetics, whereas more extreme conditions led to a shift from Avrami to diffusion kinetics, likely due to the miscibility of degradation products with polymer chains. In conclusion, the SD-PVPVA64 ASD was identified as the most balanced formulation in terms of physical and chemical stability, making it a prime candidate for further development. The study underscores the effectiveness of the APS approach, combined with chemometrics, as a robust methodology for guiding decision-making in the development of pharmaceutical amorphous formulations.

Keywords: Accelerated predictive stability, APS; Amorphous solid dispersions; Hot melt extrusion; NIR modelling; Nifedipine; Physical stability; Spray-drying.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Anne Marie Healy reports financial support was provided by Science Foundation Ireland Research Centre for Pharmaceuticals. Peter O’Connell reports a relationship with Sanofi that includes: employment. Peter O’Connell reports a relationship with Janssen Pharmaceutica NV that includes: employment. Note that given her role as journal editor, Anne Marie Healy had no involvement in the peer review of this article and had no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to another journal editor. A statement to this effect is included in the revised manuscript. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Similar articles

Publication types

Substances

LinkOut - more resources